Vulnerability in Philips Clinical Collaboration Platform
CVE-2020-16200
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not properly control the allocation and maintenance of a limited resource, thereby enabling an attacker to influence the amount of resources consumed, eventually leading to the exhaustion of available resources.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.
EPSS exploit prediction
EPSS: 0.006 (48.7th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 49th percentile — 48.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.006 · newest: 0.006 · change: 0.000
Affected products
Weakness classification (CWE)
References
- us-cert.cisa.gov/ics/advisories/icsma-20-261-01 (US Government Resource, Third Party Advisory)
- www.philips.com/a-w/security/security-advisories/product-security-2020.html
Frequently asked questions
- What is CVE-2020-16200?
- CVE-2020-16200 is a medium-severity vulnerability in Philips Clinical Collaboration Platform, classified under CWE-757. CVSS score: 6.5/10. Published 2020-09-18.
- How severe is CVE-2020-16200?
- Medium severity. CVSS v3 base score is 6.5 out of 10.